Investor deadline approaching: faruqi & faruqi, llp investigates claims on behalf of investors of kyverna therapeutics

Faruqi & faruqi, llp securities litigation partner james (josh) wilson encourages investors who suffered losses exceeding $50,000 in kyverna to contact him directly to discuss their options if you suffered losses exceeding $50,000 investing kyverna common stock pursuant and/or traceable to the offering documents (defined below) issued in connection with the company's initial public offering conducted on or about february 8, 2024 (the "ipo" or "offering") and would like to discuss your legal rights, call faruqi & faruqi partner josh wilson directly at 877-247-4292 or 212-983-9330 (ext. 1310). new york, ny / accesswire / january 7, 2025 / faruqi & faruqi, llp, a leading national securities law firm, is investigating potential claims against kyverna therapeutics, inc. ("kyverna" or the "company") (nasdaq:kytx) and reminds investors of the february 7, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the company.
KYTX Ratings Summary
KYTX Quant Ranking